Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients
Clinical trial NCT03149900 · COMPLETED
Trial details
- NCT number
- NCT03149900
- Sponsor
- Diamant Thaci
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-07-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.